AMN Q1 2026 Earnings Call Summary | Stock Taper
Logo
AMN

AMN — AMN Healthcare Services, Inc.

NYSE


Q1 2026 Earnings Call Summary

May 8, 2026

AMN Healthcare Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

  • Revenue: $1.38 billion, exceeding guidance and consensus, driven largely by $722 million in labor disruption revenue.
  • Gross Margin: 26.8%, above guidance; year-over-year decline of 190 basis points but a sequential increase of 70 basis points.
  • Adjusted EBITDA: $166 million, representing 12.1% of revenue, above guidance and up 280 basis points year-over-year.
  • Net Income: $62 million, compared to a net loss of $1 million in the prior year.
  • Cash Position: $551 million in cash and equivalents; leverage ratio improved to 1.6x.
  • SG&A Expenses: $218 million, with adjusted SG&A at $205 million, reflecting costs related to labor disruption events.

2. Strategic Updates and Business Highlights:

  • AMN successfully managed several large labor disruption events, showcasing its operational capabilities and technology investments.
  • Nurse and Allied Solutions revenue reached $1.13 billion, marking the second highest in company history, with travel nurse revenue up 13% year-over-year.
  • International staffing revenue grew by 17% quarter-over-quarter, marking the first year-over-year growth since Q4 2023.
  • The company is focusing on technology enablement, with enhancements to its WorkWise platform and AMN Passport app, leading to increased user engagement.

3. Forward Guidance and Outlook:

  • For Q2 2026, AMN expects consolidated revenue between $620 million and $635 million, with gross margin projected at 28% to 28.5%.
  • Adjusted EBITDA margin is expected to be between 6.7% and 7.2%.
  • The company anticipates Nurse and Allied Solutions revenue to be flat to down 2% year-over-year, while Physician and Leadership Solutions revenue is expected to decline by 6% to 8% year-over-year.

4. Bad News, Challenges, or Points of Concern:

  • Despite strong performance, there are concerns regarding the predictability of labor disruption revenue and the potential normalization of bill rates.
  • Physician and Leadership Solutions segment experienced a 6% year-over-year revenue decline, with locum tenens volume down 9%.
  • The Technology and Workforce Solutions segment saw a 15% year-over-year revenue decline, indicating challenges in pricing and demand.
  • Competitive pressures are evident, with some smaller players exiting the market and larger players consolidating, which could impact AMN's market position.

5. Notable Q&A Insights:

  • Discussions with major hospital operators have shifted towards sustainable workforce strategies rather than just reducing contract labor.
  • The company emphasized the importance of deepening client relationships during labor disruption events, which could lead to future revenue opportunities.
  • There is a recognition of the need for improved fill rates and bill rates, particularly in the locum tenens space, where competition remains high.
  • AMN's leadership solutions are adapting to the changing healthcare landscape, focusing on the demand for digitally fluent leaders amidst rising turnover in healthcare C-suites.

Overall, AMN Healthcare demonstrated strong financial performance in Q1 2026, but faces challenges in certain segments and must navigate a competitive landscape while focusing on sustainable growth strategies.